Ns Unibiosys Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -4.91%
- Profit Growth 15.96%
- Ebitda 21.36%
- Net Worth 28.67%
- Total Assets 19.52%
About Ns Unibiosys Medicare
Ns Unibiosys Medicare Private Limited (NUMPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 February 2013 and has a history of 11 years and 11 months. Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Niranjan Patil and Suresh Kagwade serve as directors at the Company.
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909PN2013PTC146330
- Company No.
146330
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Ns Unibiosys Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Kagwade  | Director | 21-Feb-2013 | Current |
| Niranjan Patil | Director | 21-Feb-2013 | Current |
Financial Performance of Ns Unibiosys Medicare.
Ns Unibiosys Medicare Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.91% decrease. The company also saw a substantial improvement in profitability, with a 15.96% increase in profit. The company's net worth Soared by an impressive increase of 28.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ns Unibiosys Medicare?
In 2018, Ns Unibiosys Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Primevision Pharma LlpNiranjan Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ns Unibiosys Medicare?
Unlock and access historical data on people associated with Ns Unibiosys Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ns Unibiosys Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ns Unibiosys Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.